2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphoethanolamine

Term ID

CHEBI:90579

Synonyms

(2R)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (5Z,8Z,11Z)-icosa-5,8,11-trienoate
(5Z,8Z,11Z-Eicosatrienoyl)-lysophosphatidylethanolamine
2-[(5Z,8Z,11Z)-eicosatrienoyl]-sn-glycero-3-phosphoethanolamine
LPE(0:0/20:3)
LPE(0:0/20:3n9)
LPE(0:0/20:3w9)
lyso-PE(0:0/20:3)
lyso-PE(0:0/20:3n9)
lyso-PE(0:0/20:3w9)
lyso-PE(20:3)
LysoPE(0:0/20:3(5Z,8Z,11Z))
LysoPE(0:0/20:3)
LysoPE(0:0/20:3n9)
LysoPE(0:0/20:3w9)
Lysophosphatidylethanolamine(0:0/20:3)
Lysophosphatidylethanolamine(0:0/20:3n9)
Lysophosphatidylethanolamine(0:0/20:3w9)

Definition

A lysophosphatidylethanolamine 20:3 in which the acyl group is specified as (5Z,8Z,11Z)-icosatrienoyl and is located at position 2.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: 2-acyl-sn-glycero-3-phosphoethanolamine lysophosphatidylethanolamine 20:3

2-acyl-sn-glycero-3-phosphoethanolamine lysophosphatidylethanolamine 20:3 Show first 5 Terms
has_functional_parent: (5Z,8Z,11Z)-icosatrienoic acid

(5Z,8Z,11Z)-icosatrienoic acid Show first 5 Terms
has_role: mouse metabolite

mouse metabolite Show first 5 Terms

Phenotype

Phenotype resulting from 2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphoethanolamine

Phenotype where environments contain 2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphoethanolamine

Phenotype modified by environments containing 2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphoethanolamine

Human Disease Model